|
PA
Cancer Alliance to Honor Brightbill for Strong Support of Cancer Research
PHILADELPHIA -- The
Pennsylvania Cancer Alliance (PCA), a consortium of the Commonwealth's top
cancer centers, will honor State Senate Majority Leader David J. “Chip”
Brightbill (R-48) tonight, during a reception at 5:00 p.m. in the East Wing
Rotunda of the State Capitol in Harrisburg, Pennsylvania.
Brightbill, the Senate Majority
Leader since 2000, serves the people of Lebanon County and areas of Berks,
Chester, Dauphin, and Lancaster counties. He was selected to receive the PCA's
annual award in recognition of his strong support of cancer research during his
career.
Brightbill is most noted for his
commitment to cancer research in the Commonwealth following the Master Tobacco
Settlement Agreement of 1998, which provided substantial funds to the 46 states
participating in the agreement. With his active support, Act 77 was signed into
law in 2001 dedicating all of the tobacco funds to medical research and other
health-related programs.
In addition, Brightbill helped
advance the Pennsylvania Breast and Cervical Cancer Early Screening Act, which
will go into effect after July 1, 2006. This act directs the Pennsylvania
Department of Heath to provide annual breast and cervical cancer screenings for
eligible women 40 to 49.
Brightbill also is chairman of
the Senate Rules and Executive Nominations Committee. He graduated from Penn
State University with a degree in Economics and graduated with honors from
Duquesne University School of Law. He has served as District Attorney of
Lebanon County and as a member of the Lebanon School Board.
The Pennsylvania Cancer
Alliance is working together to fight cancer in the Commonwealth of Pennsylvania
by pursuing world-class basic and clinical research to advance the standard of
cancer care and improve cancer prevention statewide. The members of the
Alliance are Pennsylvania's leading cancer centers: Drexel University,
Philadelphia; Fox Chase Cancer Center, Philadelphia; Pennsylvania State
University, Hershey; Temple University, Philadelphia; Thomas Jefferson
University, Philadelphia; University of Pennsylvania, Philadelphia; University
of Pittsburgh Cancer Institute, Pittsburgh; and The Wistar Institute,
Philadelphia.
|
